Novavax to Participate in BofA Securities 2026 Health Care Conference
Novavax (Nasdaq: NVAX) will participate in the BofA Securities 2026 Health Care Conference with a fireside chat on Wednesday, May 13, 2026 at 3:00–3:30 p.m. PT in Las Vegas.
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will participate in the BofA Securities 2026 Health Care Conference with a fireside chat on Wednesday, May 13, 2026 at 3:00–3:30 p.m. PT in Las Vegas. A webcast will be available on the company website and a replay will be accessible for 30 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NVAX
On May 8, the first trading day after this news, NVAX closed 9.53% above the previous close.
Data tracked by StockTitan Argus for the May 8 session.
Key Figures
- Conference date
- May 13, 2026
- BofA Securities 2026 Health Care Conference
- Fireside chat time
- 3:00–3:30 p.m. Pacific Time
- Scheduled conference session window
- Webcast replay window
- 30 days
- Replay availability on investor relations website
Historical Context
-
Reported Q1 2026 results with revenue decline but reiterated 2026 guidance.
-
Announced timing and access details for Q1 2026 earnings call.
-
Appointed Dr. Robert Walker as EVP and Head of Research & Development.
-
Planned participation in three March 2026 health care investor conferences.
-
Reported Q4 and full‑year 2025 results with guidance and expense reduction targets.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Details: | ||||
Fireside Chat | ||||
Date: | Wednesday, May 13, 2026 | |||
Time: | 3:00 – 3:30 p.m. Pacific Time | |||
Location: | ||||
Conference | ||||
Event: | Investor Meetings | |||
Date: | Wednesday, May 13, 2026 | |||
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-bofa-securities-2026-health-care-conference-302765891.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
